Free Trial

Pediatrix Medical Group (NYSE:MD) Sees Unusually-High Trading Volume - Still a Buy?

Pediatrix Medical Group logo with Medical background

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 2,041,377 shares changed hands during trading, an increase of 137% from the previous session's volume of 860,567 shares.The stock last traded at $13.60 and had previously closed at $13.85.

Analyst Ratings Changes

MD has been the topic of several analyst reports. Macquarie increased their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. UBS Group reduced their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Finally, Truist Financial dropped their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a report on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $16.67.

View Our Latest Research Report on Pediatrix Medical Group

Pediatrix Medical Group Stock Performance

The firm has a market cap of $1.16 billion, a price-to-earnings ratio of -11.28, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The stock has a 50-day moving average of $13.72 and a 200-day moving average of $14.03. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm's revenue was down 7.4% compared to the same quarter last year. During the same period last year, the company earned $0.20 earnings per share. As a group, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System boosted its holdings in shares of Pediatrix Medical Group by 0.9% in the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after buying an additional 752 shares during the last quarter. AlphaQuest LLC lifted its stake in Pediatrix Medical Group by 16.0% in the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after acquiring an additional 811 shares during the last quarter. SummerHaven Investment Management LLC grew its position in shares of Pediatrix Medical Group by 0.9% in the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after acquiring an additional 1,028 shares during the period. Parkside Financial Bank & Trust grew its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after acquiring an additional 1,040 shares during the period. Finally, Nomura Asset Management Co. Ltd. raised its holdings in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after purchasing an additional 1,220 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

(Get Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Further Reading

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines